Cetek wants to electrify your drug pipeline. The biotechnology company uses electrophoresis and other research technologies to identify drug candidates in its library of organic compounds. This library is built from tissue extracts from natural sources around the world. The firm also uses its core CE Assay to screen partners' libraries of synthetic compounds. Cetek has screened more than 150 targets and 6 million compounds with collaborators in the pharmaceutical and biotechnology industries.